KRAS and colorectal carcinoma: In addition, studies have found that the PDX CRC models maintain important gene mutations (e.g., KRAS) as well as gene expression, copy number changes, and microsatellite instability of the primary tumor, enabling in vivo investigations mirroring human conditions [72].